_256_384.png){kind=logo}
Digitisation | February 09, 2024
Qure.ai adds new FDA breakthrough device status for qSpot-TB
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
US FDA approval based on NEURO-TTRansform Phase III results
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Almost 300 million people globally have chronic hepatitis B
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
Subscribe To Our Newsletter & Stay Updated
